XML 63 R46.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurement (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
The following table displays our assets and liabilities measured on our consolidated balance sheets at fair value on a recurring basis as of December 31, 2021 and 2020.
Table 16.1: Assets and Liabilities Measured at Fair Value on a Recurring Basis
December 31, 2021
Fair Value Measurements Using
Netting Adjustments(1)
(Dollars in millions)Level 1Level 2Level 3Total
Assets:
Securities available for sale:
U.S. Treasury securities$9,442 $0 $0 — $9,442 
RMBS0 73,358 258 — 73,616 
CMBS0 9,360 9 — 9,369 
Other securities206 2,628 0 — 2,834 
Total securities available for sale9,648 85,346 267 — 95,261 
Loans held for sale0 1,026 0 — 1,026 
Other assets:
Derivative assets(2)
406 2,200 84 $(542)2,148 
Other(3)
526 6 41 — 573 
Total assets$10,580 $88,578 $392 $(542)$99,008 
Liabilities:
Other liabilities:
Derivative liabilities(2)
$838 $965 $65 $(544)$1,324 
Total liabilities$838 $965 $65 $(544)$1,324 
December 31, 2020
Fair Value Measurements Using
Netting Adjustments(1)
(Dollars in millions)Level 1Level 2Level 3Total
Assets:
Securities available for sale:
U.S. Treasury securities$9,318 $$— $9,318 
RMBS76,375 328 — 76,703 
CMBS11,624 111 — 11,735 
Other securities142 2,547 — 2,689 
Total securities available for sale9,460 90,546 439 — 100,445 
Loans held for sale596 — 596 
Other assets:
Derivative assets(2)
268 3,006 141 $(1,148)2,267 
Other(3)
430 552 55 — 1,037 
Total assets$10,158 $94,700 $635 $(1,148)$104,345 
Liabilities:
Other liabilities:
Derivative liabilities(2)
$271 $1,137 $110 $(739)$779 
Total liabilities$271 $1,137 $110 $(739)$779 
__________
(1)Represents balance sheet netting of derivative assets and liabilities, and related payables and receivables for cash collateral held or placed with the same counterparty. See “Note 9—Derivative Instruments and Hedging Activities” for additional information.
(2)Does not reflect $11 million and $31 million recognized as a net valuation allowance on derivative assets and liabilities for non-performance risk as of December 31, 2021 and 2020, respectively. Non-performance risk is included in derivative assets and liabilities, which are part of other assets and other liabilities on the consolidated balance sheets, and is recorded through non-interest income in the consolidated statements of income.
(3)As of December 31, 2021 and 2020, other includes retained interests in securitizations of $41 million and $55 million, deferred compensation plan assets of $490 million and $414 million, and equity securities of $42 million (including unrealized loss of $36 million) and $568 million (including unrealized gain of $535 million), respectively.
Schedule of Level 3 Inputs Reconciliation
The table below presents a reconciliation for all assets and liabilities measured and recognized at fair value on a recurring basis using significant unobservable inputs (Level 3) for the years ended December 31, 2021, 2020 and 2019. Generally, transfers into Level 3 were primarily driven by the usage of unobservable assumptions in the pricing of these financial instruments as evidenced by wider pricing variations among pricing vendors and transfers out of Level 3 were primarily driven by the usage of assumptions corroborated by market observable information as evidenced by tighter pricing among multiple pricing sources.
Table 16.2: Level 3 Recurring Fair Value Rollforward
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Year Ended December 31, 2021
Total Gains (Losses)
(Realized/Unrealized)
Net Unrealized Gains (Losses) Included in Net Income Related to Assets and Liabilities Still Held as of December 31, 2021(1)
(Dollars in millions)Balance, January 1, 2021
Included
in Net
Income(1)
Included in OCIPurchasesSalesIssuancesSettlementsTransfers
Into
Level 3
Transfers
Out of
Level 3
Balance, December 31, 2021
Securities available for sale:(2)
RMBS$328 $18 $5 $0 $0 $0 $(91)$106 $(108)$258 $15 
CMBS111 0 (2)0 0 0 (7)0 (93)9 0 
Total securities available for sale439 18 3 0 0 0 (98)106 (201)267 15 
Other assets:
Retained interests in securitizations55 (14)0 0 0 0 0 0 0 41 (14)
Net derivative assets (liabilities)(3)
31 (43)0 0 0 68 (37)6 (6)19 (20)
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Year Ended December 31, 2020
Total Gains (Losses)
(Realized/Unrealized)
Net Unrealized Gains (Losses) Included in Net Income Related to Assets and Liabilities Still Held as of December 31, 2020(1)
(Dollars in millions)Balance, January 1, 2020
Included
in Net
Income(1)
Included in OCIPurchasesSalesIssuancesSettlementsTransfers
Into
Level 3
Transfers
Out of
Level 3
Balance, December 31, 2020
Securities available for sale:(2)(4)
RMBS$433 $22 $(19)$$$$(72)$206 $(242)$328 $16 
CMBS13 (3)(9)(32)371 (229)111 
Total securities available for sale446 19 (28)(104)577 (471)439 16 
Other assets:
Retained interests in securitizations66 (11)55 (11)
Net derivative assets (liabilities)(3)
26 10 43 (37)(11)31 10 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Year Ended December 31, 2019
Total Gains (Losses)
(Realized/Unrealized)
Net Unrealized Gains (Losses) Included in Net Income Related to Assets and Liabilities Still Held as of December 31, 2019(1)
(Dollars in millions)Balance, January 1, 2019
Included
in Net
Income(1)
Included in OCIPurchasesSalesIssuancesSettlementsTransfers
Into
Level 3
Transfers
Out of
Level 3
Balance, December 31, 2019
Securities available for sale:(2)
RMBS$433 $35 $$$$$(63)$177 $(158)$429 $34 
CMBS10 (2)13 
Total securities available for sale443 35 (65)182 (158)442 34 
Other assets:
Retained interests in securitizations158 18 (110)66 (19)
Net derivative assets (liabilities)(3)
(10)(16)52 (6)26 
__________
(1)Realized gains (losses) on securities available for sale are included in net securities gains (losses) and retained interests in securitizations are reported as a component of non-interest income in our consolidated statements of income. Gains (losses) on derivatives are included as a component of net interest income or non-interest income in our consolidated statements of income.
(2)Net unrealized losses included in other comprehensive income related to Level 3 securities available for sale still held as of December 31, 2021 were $4 million. Net unrealized losses included in other comprehensive income related to Level 3 securities available for sale still held as of December 31, 2020 were $21 million. Net unrealized losses included in other comprehensive income related to Level 3 securities available for sale still held as of December 31, 2019 were $4 million.
(3)Includes derivative assets and liabilities of $84 million and $65 million, respectively, as of December 31, 2021 and $141 million and $110 million, respectively, as of December 31, 2020 and $77 million and $51 million, respectively, as of December 31, 2019.
(4)The fair value of RMBS as of January 1, 2020 includes a cumulative adjustment of $4 million from the adoption of the CECL standard.
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis Quantitative Information The following table presents the significant unobservable inputs used to determine the fair values of our Level 3 financial instruments on a recurring basis. We utilize multiple vendor pricing services to obtain fair value for our securities. Several of our vendor pricing services are only able to provide unobservable input information for a limited number of securities due to software licensing restrictions. Other vendor pricing services are able to provide unobservable input information for all securities for which they provide a valuation. As a result, the unobservable input information for the securities available for sale presented below represents a composite summary of all information we are able to obtain. The unobservable input information for all other Level 3 financial instruments is based on the assumptions used in our internal valuation models.
Table 16.3: Quantitative Information about Level 3 Fair Value Measurements
Quantitative Information about Level 3 Fair Value Measurements
(Dollars in millions)Fair Value at
December 31,
2021
Significant
Valuation
Techniques
Significant
Unobservable
Inputs
Range
Weighted
Average(1)
Securities available for sale:
RMBS$258 Discounted cash flows (vendor pricing)Yield
Voluntary prepayment rate
Default rate
Loss severity
0-21%
5-40%
1-11%
30-100%
3%
11%
2%
65%
CMBS9 Discounted cash flows (vendor pricing)Yield
1-2%
1%
Other assets:
Retained interests in securitizations(2)
41 Discounted cash flowsLife of receivables (months)
Voluntary prepayment rate
Discount rate
Default rate
Loss severity
29-36
9-18%
2-8%
3-4%
72-151%
N/A
Net derivative assets (liabilities)19 Discounted cash flowsSwap rates
1-2%
2%
Quantitative Information about Level 3 Fair Value Measurements
(Dollars in millions)Fair Value at
December 31,
2020
Significant
Valuation
Techniques
Significant
Unobservable
Inputs
Range
Weighted
Average(1)
Securities available for sale:
RMBS$328 Discounted cash flows (vendor pricing)Yield
Voluntary prepayment rate
Default rate
Loss severity
2-12%
8-15%
0-11%
30-100%
3%
10%
2%
73%
CMBS111 Discounted cash flows (vendor pricing)Yield
1-3%
2%
Other assets:
Retained interests in securitizations(2)
55 Discounted cash flowsLife of receivables (months)
Voluntary prepayment rate
Discount rate
Default rate
Loss severity
37-52
3-13%
2-12%
3-3%
55-70%
N/A
Net derivative assets (liabilities)31 Discounted cash flowsSwap rates1%1%
__________
(1)Weighted averages are calculated by using the product of the input multiplied by the relative fair value of the instruments.
(2)Due to the nature of the various mortgage securitization structures in which we have retained interests, it is not meaningful to present a consolidated weighted average for the significant unobservable inputs.
Schedule of Assets Measured at Fair Value on Nonrecurring Basis
The following table presents the carrying value of the assets measured at fair value on a nonrecurring basis and still held as of December 31, 2021 and 2020, and for which a nonrecurring fair value measurement was recorded during the year then ended.
Table 16.4: Nonrecurring Fair Value Measurements
December 31, 2021
Estimated Fair Value HierarchyTotal
(Dollars in millions)Level 2Level 3
Loans held for investment$0 $194 $194 
Loans held for sale118 0 118 
Other assets(1)
0 325 325 
Total$118 $519 $637 
December 31, 2020
Estimated Fair Value HierarchyTotal
(Dollars in millions)Level 2Level 3
Loans held for investment$$305 $305 
Other assets(1)
175 175 
Total$$480 $480 
__________
(1)As of December 31, 2021, other assets included equity method investments of $50 million, investments accounted for under measurement alternative of $29 million, repossessed assets of $40 million and long-lived assets held for sale of $206 million. As of December 31, 2020, other assets included equity investments accounted for under the measurement alternative of $25 million, repossessed assets of $42 million and long-lived assets held for sale of $108 million.
Schedule of Earnings Related to Assets Measured at Fair Value on Nonrecurring Basis
The following table presents total nonrecurring fair value measurements for the period, included in earnings, attributable to the change in fair value relating to assets that are still held at December 31, 2021 and 2020.
Table 16.5: Nonrecurring Fair Value Measurements Included in Earnings
Total Gains (Losses)
Year Ended December 31,
(Dollars in millions)20212020
Loans held for investment$2 $198 
Other assets(1)
(72)(85)
Total$(70)$113 
__________
(1)Other assets include fair value adjustments related to repossessed assets, long-lived assets held for sale and equity investments accounted for under the measurement alternative.
Schedule of Fair Value of Financial Instruments
The following table presents the carrying value and estimated fair value, including the level within the fair value hierarchy, of our financial instruments that are not measured at fair value on a recurring basis on our consolidated balance sheets as of December 31, 2021 and 2020.
Table 16.6: Fair Value of Financial Instruments
December 31, 2021
Carrying
Value
Estimated
Fair Value
Estimated Fair Value Hierarchy
(Dollars in millions)Level 1Level 2Level 3
Financial assets:
Cash and cash equivalents$21,746 $21,746 $4,164 $17,582 $0 
Restricted cash for securitization investors308 308 308 0 0 
Net loans held for investment265,910 270,508 0 0 270,508 
Loans held for sale4,862 5,091 0 5,091 0 
Interest receivable1,460 1,460 0 1,460 0 
Other investments(1)
1,344 1,344 0 1,344 0 
Financial liabilities:
Deposits with defined maturities17,923 18,062 0 18,062 0 
Securitized debt obligations14,994 15,122 0 15,122 0 
Senior and subordinated notes27,219 27,842 0 27,842 0 
Federal funds purchased and securities loaned or sold under agreements to repurchase820 820 0 820 0 
Interest payable281 281 0 281 0 
 December 31, 2020
Carrying
Value
Estimated
Fair Value
Estimated Fair Value Hierarchy
(Dollars in millions)Level 1Level 2Level 3
Financial assets:
Cash and cash equivalents$40,509 $40,509 $4,708 $35,801 $
Restricted cash for securitization investors262 262 262 
Net loans held for investment236,060 244,701 244,701 
Loans held for sale2,114 2,214 2,214 
Interest receivable1,471 1,471 1,471 
Other investments(1)
1,341 1,341 1,341 
Financial liabilities:
Deposits with defined maturities32,746 33,111 33,111 
Securitized debt obligations12,414 12,584 12,584 
Senior and subordinated notes27,382 28,282 28,282 
Federal funds purchased and securities loaned or sold under agreements to repurchase668 668 668 
Interest payable352 352 352 
__________
(1)Other investments include FHLB and Federal Reserve stock. These investments are included in other assets on our consolidated balance sheets.